About HEMA BIOLOGICS LLC
HEMA Biologics is a company focused on developing and providing treatments for rare bleeding disorders, including Hemophilia A and B with inhibitors. The company's primary product, SEVENFACT, is an injectable medicine used for the treatment and control of bleeding episodes.
Development of inhibitor bypassing agents for rare bleeding disordersProduction of injectable medicines for hemophilia treatmentMedical affairs and patient education resources
Is this your company?
Claim HEMA BIOLOGICS LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim HEMA BIOLOGICS LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.